SEC Form 4 · accession 0001193125-26-288863

Pharvaris N.V. · PHVS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Early Development

Period of report

Jun 25, 2026

Accepted (ET)

Jun 29, 2026 · 6:41 pm EDT

Rule 10b5-1 plan

yes — trade under a plan

Issuer CIK

0001830487

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jun 25, 2026	M	1,400	$2.59	A	57,850	D
Common Stock	Jun 25, 2026	M	900	$8.05	A	58,750	D
Common Stock^F2	Jun 25, 2026	S	2,300	$35.1194	D	56,450	D
Common Stock^F2,F3	Jun 25, 2026	S	2,300	$35.1242	D	131,669	I	By GrayMatters Consulting BVBA

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F4	$8.05	Jun 25, 2026	M	900	D	—	Apr 6, 2033	Common Stock	900	74,100	D
Stock Option (Right to Buy)^F5	$2.59	Jun 25, 2026	M	1,400	D	—	Jan 1, 2030	Common Stock	1,400	7,072	D

F1This is a scheduled exercise and sale from 10b5-1 trading plan.
F2The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to $35.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3GrayMatters Consulting B.V., an entity controlled by Dr. Lesage
F425% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.
F525% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.